XML 77 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (CAD)
In Thousands, unless otherwise specified
Mar. 31, 2013
Mar. 31, 2012
Current assets    
Cash and cash equivalents 598 1,400
Accounts receivable, net (note 5 and 17(d)) 100,469 214,129
Unbilled revenue (note 6) 56,183 86,859
Inventories (note 7) 5,751 11,855
Prepaid expenses and deposits (note 8) 2,498 6,315
Investment in and advances to unconsolidated joint venture (note 9) 0 1,574
Assets held for sale (note 10, 23(b) and 17(a)) 157,464 1,841
Deferred tax assets (note 11) 33,694 2,991
Total current assets 356,657 326,964
Property, plant and equipment, net (note 12) 274,246 312,775
Other assets (note 13(a)) 14,362 19,902
Goodwill (note 14) 0 32,901
Deferred tax assets (note 11) 14,673 57,451
Total Assets 659,938 749,993
Current liabilities    
Accounts payable 73,727 171,130
Accrued liabilities (note 15) 32,482 36,795
Billings in excess of costs incurred and estimated earnings on uncompleted contracts (note 6) 7,085 7,514
Current portion of long term debt (note 16(a)) 21,409 14,402
Current portion of derivative financial instruments (note 17(a)) 4,261 3,220
Liabilities held for sale (note 23(b)) 38,846 0
Deferred tax liabilities (note 11) 13,392 21,512
Total current liabilities 191,202 254,573
Long term debt (note 16(a)) 290,655 300,066
Derivative financial instruments (note 17(a)) 2,180 5,926
Other long term obligations (note 18(a)) 6,746 8,860
Deferred tax liabilities (note 11) 41,211 52,788
Total liabilities 531,994 622,213
Shareholders' equity    
Common shares (authorized – unlimited number of voting common shares; issued and outstanding – March 31, 2013 - 36,251,006 (March 31, 2012 - 36,251,006) (note 19(a)) 304,908 304,908
Additional paid-in capital 10,307 8,711
Deficit (187,283) (185,820)
Accumulated other comprehensive income (loss) 12 (19)
Total shareholders' equity 127,944 127,780
Total liabilities and shareholders' equity 659,938 749,993
Commitments (note 20)      
Contingencies (note 21)